These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22572524)

  • 1. Mean platelet volume is increased in chronic hepatitis C patients with advanced fibrosis.
    Purnak T; Olmez S; Torun S; Efe C; Sayilir A; Ozaslan E; Tenlik I; Kalkan IH; Beyazit Y; Yuksel O
    Clin Res Hepatol Gastroenterol; 2013 Feb; 37(1):41-6. PubMed ID: 22572524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mean platelet volume and red cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in patients with chronic hepatitis C.
    Karagöz E; Tanoğlu A; Ülçay A; Erdem H; Turhan V; Kara M; Yazgan Y
    Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):744-8. PubMed ID: 27101403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients.
    Karagoz E; Ulcay A; Tanoglu A; Kara M; Turhan V; Erdem H; Oncul O; Gorenek L
    Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1320-4. PubMed ID: 25210777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mean platelet volume as a fibrosis marker in patients with chronic hepatitis B.
    Ekiz F; Yüksel O; Koçak E; Yılmaz B; Altınbaş A; Çoban S; Yüksel I; Üsküdar O; Köklü S
    J Clin Lab Anal; 2011; 25(3):162-5. PubMed ID: 21567462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can mean platelet volume determine the severity of liver fibrosis or inflammation in patients with chronic hepatitis B?
    Ceylan B; Fincanci M; Yardimci C; Eren G; Tözalgan Ü; Müderrisoğlu C; Paşaoğlu E
    Eur J Gastroenterol Hepatol; 2013 May; 25(5):606-12. PubMed ID: 23325286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.
    Omran MM; Farid K; Emran TM; Attallah AA
    Arab J Gastroenterol; 2011 Jun; 12(2):74-9. PubMed ID: 21684477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mean platelet volume is a useful indicator of systemic inflammation in cirrhotic patients with ascitic fluid infection.
    Suvak B; Torun S; Yildiz H; Sayilir A; Yesil Y; Tas A; Beyazit Y; Sasmaz N; Kayaçetin E
    Ann Hepatol; 2013; 12(2):294-300. PubMed ID: 23396741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
    Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
    Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis.
    Kayadibi H; Yasar B; Ozkara S; Serdar MA; Kurdas OO; Gonen C
    Scand J Clin Lab Invest; 2014 Apr; 74(3):240-7. PubMed ID: 24460024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
    Lichtinghagen R; Pietsch D; Bantel H; Manns MP; Brand K; Bahr MJ
    J Hepatol; 2013 Aug; 59(2):236-42. PubMed ID: 23523583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of diagnostic accuracy of APRI for prediction of fibrosis in hepatitis C patients.
    Khan DA; Fatima-Tuz-Zuhra ; Khan FA; Mubarak A
    J Ayub Med Coll Abbottabad; 2008; 20(4):122-6. PubMed ID: 19999223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of liver fibrosis in chronic viral hepatitis C infection using the Sabadell NIHCED (Non-Invasive Hepatitis-C-Related Cirrhosis Early Detection) index.
    Bejarano G; Vergara M; Dalmau B; Puig J; Bella MR; Suárez D; Calvet X
    Rev Esp Enferm Dig; 2009 May; 101(5):325-35. PubMed ID: 19527078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
    Vardar R; Vardar E; Demiri S; Sayhan SE; Bayol U; Yildiz C; Postaci H
    Hepatogastroenterology; 2009; 56(94-95):1459-65. PubMed ID: 19950810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum angiotensin-converting enzyme level as a marker of fibrosis in patients with chronic hepatitis B.
    Purnak T; Beyazit Y; Oztas E; Yesil Y; Efe C; Torun S; Celik T; Tenlik I; Kurt M; Ozaslan E
    J Renin Angiotensin Aldosterone Syst; 2012 Jun; 13(2):244-9. PubMed ID: 22277254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.
    Wai CT; Greenson JK; Fontana RJ; Kalbfleisch JD; Marrero JA; Conjeevaram HS; Lok AS
    Hepatology; 2003 Aug; 38(2):518-26. PubMed ID: 12883497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
    Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.
    Carvalho-Filho RJ; Schiavon LL; Narciso-Schiavon JL; Sampaio JP; Lanzoni VP; Ferraz ML; Silva AE
    Liver Int; 2008 Apr; 28(4):486-93. PubMed ID: 18339075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retrospective study of FibroScan, APRI, FIB-4 and FORNS indexes compared with liver biopsy in the evaluation of liver fibrosis in patients with chronic hepatitis C monoinfection and HIV coinfection].
    González Guilabert MI; Hinojosa Mena-Bernal C; del Pozo González J; del Pozo Pérez MA
    Gastroenterol Hepatol; 2010; 33(6):425-32. PubMed ID: 20471720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLATELET INDICES AND LIVER FIBROSIS EVALUATION IN CHRONIC HEPATITIS C.
    Gîrleanu I; Trifan A; Sîngeap AM; Stoica OC; Cojocariu C; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):55-61. PubMed ID: 27125073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients.
    Patel K; Gordon SC; Jacobson I; Hézode C; Oh E; Smith KM; Pawlotsky JM; McHutchison JG
    J Hepatol; 2004 Dec; 41(6):935-42. PubMed ID: 15582126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.